Skip to content

Price / sales at other companies

HealthStream logo
HealthStreamHSTM
-1.4×
Huron Consulting Group logo
Huron Consulting GroupHURN
1.2×-0.4×
Doximity logo
DoximityDOCS
6.7×-12.4×
TruBridge, Inc. logo
TruBridge, Inc.TBRG
0.6×-0.6×
Hinge Health, Inc. logo
Hinge Health, Inc.HNGE
4.7×
Solventum logo
SolventumSOLV
1.4×-0.2×

Other financials

Income statement

See full
Revenue$34.8M+3.7%
Operating income$5.6M-35.8%
Net income$3.2M+11.1%
EPS (diluted)$12.50+4,708%

Balance sheet

See full
Cash & equivalents$2.5M+1.8%
Total debt$74.0M+26.2%
Total equity$13.5M-54.5%
Total assets$134.6M-0.5%

Cash flow

See full
Operating cash flow$7.2M+8.0%
CapEx$1.8M-38.6%
Free cash flow$5.3M+46.1%

Valuation

See full
Market cap$462.9M+22.8%
Enterprise value$534.37M+23.3%
P/E38.8×+21.3×

Profitability

See full
Operating margin16.4%-8.2pp
Net margin8.6%-6.6pp
FCF margin12.6%+2.0pp

Returns & leverage

See full
Return on equity55.2%-9.3pp
Debt / equity5.5×+3.5×
Current ratio0.5×0.0×

Where this comes from

Calculated from National Research Corporation’s reported figures.

Based on the most recent quarter.

The official record: National Research Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about National Research Corporation's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is National Research Corporation's price / sales?
National Research Corporation (NRC) reported price / sales of 2.8× in Q1 2026.
How has National Research Corporation's price / sales changed year-over-year?
National Research Corporation's price / sales increased by 34.0% year-over-year, from 2.1× to 2.8×.
What is the long-term trend for National Research Corporation's price / sales?
Over 5 years (2020 to 2025), National Research Corporation's price / sales has grown at a -17.6% compound annual growth rate (CAGR), from 8.2× to 3.1×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.